Related Experiment Videos
The commercialization of human genetics: profits and problems
1Health Law Institute, Faculty of Law, University of Alberta, Edmonton, Canada. tcaulfld@ualberta.ca
Molecular Medicine Today
|May 8, 1998
Summary
Academic-industry collaborations in genetics are rising, offering funding and innovation. However, this commercialization may impact academic freedom and clinical research progress.
Area of Science:
- Genetics and Genomics
- Biotechnology
- Healthcare Innovation
Background:
- Increasing private sector investment in genetic research.
- Growing number of academic-industry partnerships in genetics.
- Genetics is a key tool for healthcare, driving diagnostics and drug discovery.
Purpose of the Study:
- To explore the costs associated with the commercialization of academic genetic research.
- To examine the potential impact of commercialization on academic freedom.
- To assess the effects on clinical research progress and societal views on health.
Main Methods:
- Literature review of academic-industry collaborations in genetics.
- Analysis of case studies on commercialized genetic research.
- Discussion of ethical and practical implications.
Main Results:
- Commercialization offers financial benefits and accelerates innovation.
- Potential risks include compromised academic integrity and research direction.
- Impacts on clinical research timelines and patient access need consideration.
Conclusions:
- The rise in private funding for genetics presents both opportunities and challenges.
- Careful management is needed to balance commercial interests with academic principles.
- Ongoing evaluation is crucial to ensure research benefits society without undue compromise.